Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815301) titled 'Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: First Affiliated Hospital of Wenzhou Medical University

Condition: Obstructive Hypertrophic Cardiomyopathy (oHCM)

Intervention: Drug: Beta-Blocker Sequential Tapering and Discontinuation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 2026

Target Sample Size: 286

Countries of ...